Recurrent ovarian carcinoma: Retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent
- 1 June 1985
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 21 (2) , 167-176
- https://doi.org/10.1016/0090-8258(85)90249-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdensCancer, 1983
- cis-Platinum in gynecologic cancerAmerican Journal of Obstetrics and Gynecology, 1981
- Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycinCancer, 1981
- Combination chemotherapy of advanced ovarian cancer with cyclophosphamide (C), hexamethylmelamine (H), adriamycin (A) and diamminedichloroplatinum (D) — The “CHAD” regimenGynecologic Oncology, 1980
- Toxicity of Cis-diamminedichloroplatinum II given in a two-hour outpatient regimen of diuresis and hydrationCancer, 1980
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- Intensive Surgical and Chemotherapeutic Management of Advanced Ovarian CancerSurgical Clinics of North America, 1978
- Second trial drugs in ovarian cancerGynecologic Oncology, 1977
- Management of Ovarian CarcinomaNew England Journal of Medicine, 1976
- Chemotherapy of ovarian cancer. New Approaches to TreatmentCancer, 1972